Firm charged with fraudulently marketing spinal medical device
Submitted by admin on October 28, 2009 – 9:57 amNo Comment | 35 views
A medical technology company has been accused by federal prosecutors of fraudulently marketing devices used during spinal and bone surgeries.
The Justice Department announced on Wednesday that Hopkinton, Mass.-based Stryker Biotech, its former president Mark Philip and three sales managers had been charged with five counts of wire fraud and one count of conspiracy.
Stryker and Philip were also charged with making false statements to the Food and Drug Administration.
Related posts:
- Despite record fine for Pfizer, critics assert misleading drug marketing unlikely to end
- Much-criticised FDA medical device approvals get external review
- FDA Medical Device Head Resigns
- SC lawsuit over drug marketing spotlights sales irregularities tied to Zyprexa prescriptions
- Senate Hearing Highlights Victim’s Medtronic Medical Device Nightmare
